Why is Medicamen Biotec falling/rising?

As of 07-Aug, Medicamen Biotech Ltd is currently priced at Rs. 374.30, reflecting a decline of Rs. 4.3 or 1.14%. The stock has recently hit a new 52-week low of Rs. 362.95 and has been on a downward trend, having fallen consecutively for the last four days, resulting in a total drop of 3.16% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 30.88% against the 5-day average, suggesting a decline in investor participation.
In the broader market context, Medicamen Biotech's performance has been notably weaker than the benchmark Sensex, with a 1-week return of -3.04% compared to the Sensex's -0.69%. Over the past month, the stock has decreased by 7.06%, while the Sensex has only fallen by 3.38%. Year-to-date, Medicamen Biotech has seen a substantial decline of 26.50%, contrasting sharply with the Sensex's gain of 3.18%. This underperformance highlights the challenges faced by the company in attracting investor interest and maintaining stock value amidst broader market conditions.